• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KIF11 是甲状腺癌治疗的一个有前途的治疗靶点。

KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment.

机构信息

Department of Clinical Laboratory, The Secondary Hospital of Tianjin Medical University, Tianjin, China.

Department of Pancreatic Cancer, Tianjin Tumor Hospital, Tianjin, China.

出版信息

Comput Math Methods Med. 2022 Aug 16;2022:6426800. doi: 10.1155/2022/6426800. eCollection 2022.

DOI:10.1155/2022/6426800
PMID:36017147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9398805/
Abstract

OBJECTIVE

To assess KIF11 expression in human thyroid tumor tissues and further evaluate its involvement in thyroid cancer.

METHODS

The expression of KIF11 in 71 cases of thyroid carcinoma as well as corresponding tissues was detected by the immunohistochemical (IHC) method. Patients were divided into the high KIF11 expression as well as low expression groups based on the staining levels. In addition, to study the relationship between the expression of KIF11 as well as clinicopathological features, the effects of KIF11 were detected on the proliferation, apoptosis, and cell cycle of two types of thyroid cancer cells, TPC-1 and KTC-1, through colony formation assays, MTT assays, and FCM assays, respectively. We further assessed the potential effects of KIF11 on tumor growth using an animal model.

RESULTS

The significantly high expression of KIF11 in thyroid tumor tissues was revealed, and the correlations between KIF11 expression levels as well as clinical pathological features (T stage and intraglandular dissemination) of patients were revealed. We further noticed that KIF11 knockdown remarkably suppressed thyroid cancer cell proliferation as well as induced cell apoptosis of thyroid cancer cells. Additionally, KIF11 contributed to tumor growth of thyroid cancer cells in mice.

CONCLUSIONS

We noticed the involvement of KIF11 in the progression of thyroid cancer.

摘要

目的

评估 KIF11 在人甲状腺肿瘤组织中的表达,并进一步评估其在甲状腺癌中的作用。

方法

采用免疫组织化学(IHC)方法检测 71 例甲状腺癌及相应组织中 KIF11 的表达。根据染色水平将患者分为 KIF11 高表达组和低表达组。此外,为了研究 KIF11 表达与临床病理特征的关系,通过集落形成实验、MTT 实验和 FCM 实验分别检测 KIF11 对两种甲状腺癌细胞 TPC-1 和 KTC-1 的增殖、凋亡和细胞周期的影响。我们还使用动物模型评估了 KIF11 对肿瘤生长的潜在影响。

结果

揭示了 KIF11 在甲状腺肿瘤组织中表达明显升高,并揭示了 KIF11 表达水平与患者临床病理特征(T 分期和腺内播散)之间的相关性。我们进一步注意到,KIF11 敲低显著抑制了甲状腺癌细胞的增殖,并诱导了甲状腺癌细胞的凋亡。此外,KIF11 促进了甲状腺癌细胞在小鼠中的肿瘤生长。

结论

我们注意到 KIF11 参与了甲状腺癌的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/1d980b39dfb2/CMMM2022-6426800.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/3c131b977a09/CMMM2022-6426800.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/b954a9706e49/CMMM2022-6426800.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/a55382028303/CMMM2022-6426800.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/8a28c76e814c/CMMM2022-6426800.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/f4e74a9193af/CMMM2022-6426800.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/1d980b39dfb2/CMMM2022-6426800.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/3c131b977a09/CMMM2022-6426800.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/b954a9706e49/CMMM2022-6426800.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/a55382028303/CMMM2022-6426800.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/8a28c76e814c/CMMM2022-6426800.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/f4e74a9193af/CMMM2022-6426800.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be08/9398805/1d980b39dfb2/CMMM2022-6426800.006.jpg

相似文献

1
KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment.KIF11 是甲状腺癌治疗的一个有前途的治疗靶点。
Comput Math Methods Med. 2022 Aug 16;2022:6426800. doi: 10.1155/2022/6426800. eCollection 2022.
2
Identification of PTK7 as a promising therapeutic target for thyroid cancer.鉴定 PTK7 为甲状腺癌有前景的治疗靶点。
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6809-6817. doi: 10.26355/eurrev_202006_21670.
3
KIF11 Promotes Proliferation of Hepatocellular Carcinoma among Patients with Liver Cancers.驱动蛋白家族成员11(KIF11)促进肝癌患者中肝细胞癌的增殖。
Biomed Res Int. 2021 Jan 4;2021:2676745. doi: 10.1155/2021/2676745. eCollection 2021.
4
ASPM promotes migration and invasion of anaplastic thyroid carcinoma by stabilizing KIF11.ASPM 通过稳定 KIF11 促进间变性甲状腺癌的迁移和侵袭。
Cell Biol Int. 2023 Jul;47(7):1209-1221. doi: 10.1002/cbin.12012. Epub 2023 Mar 8.
5
KIF11 as a potential cancer prognostic marker promotes tumorigenesis in children with Wilms tumor.KIF11 作为一种潜在的癌症预后标志物,促进儿童肾母细胞瘤的肿瘤发生。
Pediatr Hematol Oncol. 2022 Mar;39(2):145-157. doi: 10.1080/08880018.2021.1953655. Epub 2021 Aug 11.
6
FK506-binding protein 5 promotes the progression of papillary thyroid carcinoma.FK506结合蛋白5促进甲状腺乳头状癌的进展。
J Int Med Res. 2021 Apr;49(4):3000605211008325. doi: 10.1177/03000605211008325.
7
LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma.LDOC1通过抑制甲状腺乳头状癌中NF-κB的激活来抑制增殖并促进凋亡。
J Exp Clin Cancer Res. 2015 Dec 4;34:146. doi: 10.1186/s13046-015-0265-z.
8
Kinesin family member 23 (KIF23) contributes to the progression of bladder cancer cells in vitro and in vivo.驱动蛋白家族成员23(KIF23)在体外和体内均促进膀胱癌细胞的进展。
Neoplasma. 2021 Mar;68(2):298-306. doi: 10.4149/neo_2020_200803N808. Epub 2020 Nov 25.
9
tRNA-Derived Fragment tRF-18 Facilitates Cell Proliferation and Inhibits Cell Apoptosis via Modulating KIF1B in Papillary Thyroid Carcinoma.tRNA 衍生片段 tRF-18 通过调节甲状腺乳头状癌中的 KIF1B 促进细胞增殖并抑制细胞凋亡。
Crit Rev Eukaryot Gene Expr. 2022;32(5):21-31. doi: 10.1615/CritRevEukaryotGeneExpr.2022040682.
10
Kinesin family member 11 promotes progression of hepatocellular carcinoma via the OCT4 pathway.驱动蛋白家族成员 11 通过 OCT4 通路促进肝细胞癌的进展。
Funct Integr Genomics. 2023 Aug 30;23(3):284. doi: 10.1007/s10142-023-01209-7.

引用本文的文献

1
Intraglandular dissemination: a special pathological feature.腺体内播散:一种特殊的病理特征。
Front Oncol. 2024 Jul 29;14:1428274. doi: 10.3389/fonc.2024.1428274. eCollection 2024.
2
Eg5 and Diseases: From the Well-Known Role in Cancer to the Less-Known Activity in Noncancerous Pathological Conditions.驱动蛋白样蛋白5(Eg5)与疾病:从其在癌症中的广为人知的作用到在非癌性病理状况下鲜为人知的活性
Biochem Res Int. 2024 Jun 20;2024:3649912. doi: 10.1155/2024/3649912. eCollection 2024.
3
Retracted: KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment.

本文引用的文献

1
Identification of Lysosome-Associated Protein Transmembrane-4 as a Novel Therapeutic Target for Osteosarcoma Treatment.鉴定溶酶体相关蛋白跨膜蛋白 4 为骨肉瘤治疗的新靶点。
Orthop Surg. 2020 Aug;12(4):1253-1260. doi: 10.1111/os.12692. Epub 2020 Jun 18.
2
Identification of KIF11 As a Novel Target in Meningioma.鉴定KIF11作为脑膜瘤的新靶点
Cancers (Basel). 2019 Apr 15;11(4):545. doi: 10.3390/cancers11040545.
3
High kinesin family member 11 expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
撤回:驱动蛋白家族成员11(KIF11)是甲状腺癌治疗中一个有前景的治疗靶点。
Comput Math Methods Med. 2023 Jul 26;2023:9813737. doi: 10.1155/2023/9813737. eCollection 2023.
4
Identification of Promising Drug Candidates against Prostate Cancer through Computationally-Driven Drug Repurposing.通过计算驱动的药物再利用鉴定治疗前列腺癌的有前途的候选药物。
Int J Mol Sci. 2023 Feb 5;24(4):3135. doi: 10.3390/ijms24043135.
高驱动蛋白家族成员 11 的表达预测透明细胞肾细胞癌患者的预后不良。
J Clin Pathol. 2019 May;72(5):354-362. doi: 10.1136/jclinpath-2018-205390. Epub 2019 Feb 28.
4
Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer.分化型甲状腺癌的临床评估与危险分层。
Endocrinol Metab Clin North Am. 2019 Mar;48(1):99-108. doi: 10.1016/j.ecl.2018.11.002.
5
KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer.KIF11 作为一种致癌基因发挥作用,并与乳腺癌不良预后相关。
Cancer Res Treat. 2019 Jul;51(3):1207-1221. doi: 10.4143/crt.2018.460. Epub 2018 Dec 27.
6
KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.KIF14 促进肿瘤进展和转移,是人类胃癌不良预后的独立预测因子。
Biochim Biophys Acta Mol Basis Dis. 2019 Jan;1865(1):181-192. doi: 10.1016/j.bbadis.2018.10.039. Epub 2018 Nov 4.
7
Update on multikinase inhibitor therapy for differentiated thyroid cancer.分化型甲状腺癌多激酶抑制剂治疗的最新进展
Drugs Today (Barc). 2018 Sep;54(9):535-545. doi: 10.1358/dot.2018.54.9.2878150.
8
Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.甲状腺癌:按年龄、性别、种族、分期、队列进入时间周期和疾病持续时间对六种甲状腺癌组织学亚型进行的20年死亡率和生存率比较分析(SEER*Stat 8.3.2) 对1993 - 2013年诊断的145,457例病例的系统评价
J Insur Med. 2018 Jan;47(3):143-158. doi: 10.17849/insm-47-03-143-158.1.
9
Death receptor 6 promotes ovarian cancer cell migration through KIF11.死亡受体6通过驱动蛋白家族成员11促进卵巢癌细胞迁移。
FEBS Open Bio. 2018 Aug 7;8(9):1497-1507. doi: 10.1002/2211-5463.12492. eCollection 2018 Sep.
10
Meiotic arrest and spindle defects are associated with altered KIF11 expression in porcine oocytes.减数分裂阻滞和纺锤体缺陷与猪卵母细胞中KIF11表达的改变有关。
Environ Mol Mutagen. 2018 Dec;59(9):805-812. doi: 10.1002/em.22213. Epub 2018 Aug 28.